{"url_path":"/sec/txmd/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 Unregistered sales of equity securities and use of proceeds**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-12","source_url":"https://www.sec.gov/Archives/edgar/data/25743/0001213900-26-055081-index.html","accession_number":"0001213900-26-055081","cik":"0000025743","ticker":"TXMD","issuer_name":"TherapeuticsMD, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/25743/0001213900-26-055081-index.html","primary_entity_key":"0000025743","primary_entity_name":"TherapeuticsMD, Inc."},"word_count":12,"has_tables":true,"body_markdown":"** **\n\n**Item 2. Unregistered sales of equity securities and use of proceeds**\n\n \n\nNone."}